Molecular programs defining tumor-specific T-cell dysfunction and reprogrammability.

被引：0
|
作者：
Schietinger, Andrea [1 ]
机构：
[1] Sloan Kettering Inst, New York, NY USA
来源：
CANCER IMMUNOLOGY RESEARCH | 2020年 / 8卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA14
引用
收藏
页码：20 / 20
页数：1
相关论文
共 50 条
  • [41] An oncolytic adenovirus redirected with a tumor-specific T cell
    Sebestyen, Zsolt
    de Vrij, Jeroen
    Magnusson, Maria
    Debets, Reno
    Willemsen, Ralph
    HUMAN GENE THERAPY, 2007, 18 (10) : 978 - 978
  • [42] Dendritic cells prolong tumor-specific T-cell survival and effector function after interaction with tumor targets
    Mailliard, RB
    Lotze, MT
    CLINICAL CANCER RESEARCH, 2001, 7 (03) : 980S - 988S
  • [43] The effects of targeted immune-regulatory strategies on tumor-specific T-cell responses in vitro
    Presti, Mario
    Westergaard, Marie Christine Wulff
    Draghi, Arianna
    Chamberlain, Christopher Aled
    Gokuldass, Aishwarya
    Svane, Inge Marie
    Donia, Marco
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (06) : 1771 - 1776
  • [44] Abscopal Effects With Hypofractionated Schedules Extending Into the Effector Phase of the Tumor-Specific T-Cell Response
    Zhang, Xuanwei
    Niedermann, Gabriele
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 101 (01): : 63 - 73
  • [45] The effects of targeted immune-regulatory strategies on tumor-specific T-cell responses in vitro
    Mario Presti
    Marie Christine Wulff Westergaard
    Arianna Draghi
    Christopher Aled Chamberlain
    Aishwarya Gokuldass
    Inge Marie Svane
    Marco Donia
    Cancer Immunology, Immunotherapy, 2021, 70 : 1771 - 1776
  • [46] Human autologous tumor-specific T-cell responses induced by liposomal delivery of a lymphoma antigen
    Neelapu, SS
    Baskar, S
    Gause, BL
    Kobrin, CB
    Watson, TM
    Frye, AR
    Pennington, R
    Harvey, L
    Jaffe, ES
    Robb, RJ
    Popescu, MC
    Kwak, LW
    CLINICAL CANCER RESEARCH, 2004, 10 (24) : 8309 - 8317
  • [47] DISSECTION OF A TUMOR-SPECIFIC TRANSPLANTATION ANTIGEN USING VARIANT TUMOR CLONES SELECTED BY T-CELL LINES INVITRO
    WORTZEL, RD
    URBAN, JL
    PHILIPPS, C
    SCHREIBER, H
    FEDERATION PROCEEDINGS, 1982, 41 (03) : 726 - 726
  • [48] Frameshift peptide-derived T-cell epitopes: a source of novel tumor-specific antigens
    Linnebacher, M
    Gebert, J
    Rudy, W
    Woerner, S
    Yuan, YP
    Bork, P
    Doeberitz, MV
    INTERNATIONAL JOURNAL OF CANCER, 2001, 93 (01) : 6 - 11
  • [49] Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40
    Eduardo M. Sotomayor
    Ivan Borrello
    Erev Tubb
    Frédérique-Marie Rattis
    Harold Bien
    Zhengbin Lu
    Steve Fein
    Stephen Schoenberger
    Hyam I. Levitsky
    Nature Medicine, 1999, 5 : 780 - 787
  • [50] Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40
    Sotomayor, EM
    Borrello, I
    Tubb, E
    Rattis, FM
    Bien, H
    Lu, ZB
    Fein, S
    Schoenberger, S
    Levitsky, HI
    NATURE MEDICINE, 1999, 5 (07) : 780 - 787
12345